VP, Corporate Development & Strategic Partnerships

Parker Institute for Cancer Immunotherapy•San Francisco, CA

About The Position

The Parker Institute for Cancer Immunotherapy (PICI) is actively seeking a high-impact, results-driven executive to fill the role of Vice President of Corporate Development and Strategic Partnerships. This is a unique and pivotal leadership position, designed to be strategically situated at the convergence of non-profit mission, transformative drug discovery, and commercial venture creation. This role moves distinctly beyond the scope of conventional non-profit corporate relations. The successful candidate will be the primary driver responsible for a core PICI strategic objective: Building a Sustainable Financial Engine . This involves the proactive establishment of high-value, mutually beneficial collaborations with the global biopharmaceutical industry and the systematic identification and engagement of institutional investors and corporate entities interested in PICI’s highly curated, consortium-wide innovation pipeline. This executive must possess the sophisticated commercial acumen to translate PICI’s world-class scientific advancements, robust clinical portfolio achievements, and unique network assets into quantifiable, compelling partnership and revenue-generation opportunities that drive the institute's long-term mission and financial sustainability.

Requirements

A mandatory minimum of ten (10) years of progressive, senior-level experience in Corporate Development, Business Development, Alliance Management, or Investment Banking specifically within the biotechnology, pharmaceutical, or venture-backed life sciences sectors is required.
A Bachelor's degree from an accredited institution is required. An advanced degree is highly preferred, including but not limited to an MBA, a Master of Science (MS) in a relevant scientific discipline, or a Juris Doctor (JD), or equivalent demonstrable experience in a relevant technical or commercial field.
The candidate must provide clear evidence of a proven capacity to successfully commercialize intellectual property, proprietary assets, or complex strategic collaborations derived from academic scientific networks, research consortia, or highly matrixed organizations.
A comprehensive and profound understanding of the entire drug discovery and development lifecycle, from target identification through clinical development and commercial launch, is essential. Specific, deep domain expertise within the therapeutic areas of Oncology and Immunology is mandatory.
A documented history of successfully negotiating and executing high-value transactions—specifically those valued in the six- and seven-figure range (USD) or higher—is a mandatory requirement for this executive role.
The role demands highly effective Stakeholder Management skills across diverse and powerful constituencies, including leading academic principal investigators, philanthropic donors, scientific leaders, and industry executives. This must be coupled with a capacity for mission-aligned, strategic communication that can articulate complex science into clear commercial value propositions.
Willingness to travel domestically and internationally as required to successfully execute the event portfolio.